Imcivree

Rhythm's Imcivree Scores FDA Approval in Bardet-Biedl Syndrome
BioSpace
Fri, 06/17/22 - 10:29 am
Rhythm Pharmaceuticals
Imcivree
Bardet-Biedl syndrome
FDA